Navigation Links
Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study
Date:10/18/2010

2.5 cm was specified in the protocol as the primary threshold of impairment for the purpose of performing the statistical analyses.  In March 2010, the FDA informed Transcept that the statistical methodology proposed by Transcept, a symmetry analysis, was a reasonable approach to measure potential next morning driving impairment.  

For reference, a 0.05% blood alcohol concentration has been associated with a change in SDLP of 2.4 cm, and a blood level of 0.08% has been associated with a mean change in SDLP of 4.2 cm (Brookhuis, Human Psychopharmacology: Clinical and Experimental, Vol. 13, 1998).  A blood alcohol concentration of 0.08% is the legal limit generally applicable for driving in the United States.

Driving data: 4 hours after middle of the night Intermezzo® dosing The 4-hour Intermezzo® treatment arm was included to represent dosing in accordance with proposed label instructions. The primary statistical analysis used in the Intermezzo® highway driving study, known as a symmetry analysis, showed no statistically significant drug effect on driving performance in subjects who began driving an automobile four hours after receiving a middle of the night dose of Intermezzo®.  A secondary analysis that evaluated mean differences in SDLP between Intermezzo® and placebo administered four hours prior to driving showed a difference of 0.8 cm, which was statistically significant.

Driving data: 3 hours after middle of the night Intermezzo® dosing The 3-hour arm was included in the study to help the FDA characterize the safety profile of Intermezzo® if it were not used as directed and taken with less than four hours before driving.  The symmetry analysis showed statistically significant drug effect on driving performance in subjects who began driving an automobile three hours after receiving a middle of the n
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Transcept Pharmaceuticals to Host Conference Call to Discuss Preliminary Analysis of Intermezzo® Highway Driving Study
2. Transcept Pharmaceuticals to Present at Newsmakers in the Biotech Industry Conference
3. Transcept Pharmaceuticals to Present at BIO Investor Forum
4. Transcept Pharmaceuticals to Present at UBS Global Life Sciences Conference
5. Transcept Pharmaceuticals to Present at Rodman & Renshaw and Stifel Nicolaus Investor Conferences in September 2010
6. Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R)
7. Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo(R) Complete Response Letter
8. Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results
9. Transcept Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference on November 17
10. Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12
11. Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo(R) New Drug Application
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... 31, 2015 BioLight ... BLGTY) ("BioLight" or the "Company"), a firm that ... ophthalmology and cancer diagnostics, today announced that its ... identified several new genetic markers with high potential ... treated with bisphosphonate drugs and was able to ...
(Date:8/31/2015)... , Aug. 31, 2015  Asterias Biotherapeutics, Inc. ... the emerging field of regenerative medicine, today announced ... Chicago -based Rush University Medical ... activity of escalating doses of AST-OPC1 (oligodendrocyte progenitor ... motor complete cervical spinal cord injury (SCI). This ...
(Date:8/31/2015)... ADELAIDE, Australia , Aug. 31, 2015 ... the discovery and development of innovative therapeutics for the ... and cancer, today announced that its BNC101 IND submission ... Administration (FDA). Bionomics plans to initiate a Phase 1 ... in patients with metastatic pancreatic cancer prior to 31 ...
Breaking Medicine Technology:BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 2BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 2Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 3Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 4
... Hologic, Inc. (Hologic or the Company) (Nasdaq: ... of premium diagnostics products, medical imaging systems and surgical products ... on new, ready to market technologies in women,s imaging at ... meeting of the European Society of Radiology in Vienna, Austria, ...
... Fla., Feb. 8, 2011 In the Third Quarter of ... MARKETS: ICBU) has elected to change the company name to ... take control of ICBU with the objective of propelling the ... has opted to alter the basic structure of the firm ...
Cached Medicine Technology:Hologic Targets Women's Health Professionals at ECR 2011 2Hologic Targets Women's Health Professionals at ECR 2011 3Hologic Targets Women's Health Professionals at ECR 2011 4Hologic Targets Women's Health Professionals at ECR 2011 5ICBU Announces Corporate Reorganization and Business Plan 2ICBU Announces Corporate Reorganization and Business Plan 3
(Date:8/31/2015)... ... August 31, 2015 , ... Castle Dermatology Institute now welcomes San ... is a graduate of the University of California, Los Angeles. He graduated summa cum ... University of California, Irvine Medical School. As a nationally recognized Regents Scholar, Dr. Ghasri ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... to future-proof its content management system (CMS) and make website updates quicker and ... in making the websites of the Bundesliga (the German equivalent of the U.S. ...
(Date:8/31/2015)... ... August 31, 2015 , ... "While working ... that could effectively deliver oxygen with a lower risk of failure," explained an ... I invented the Adam Device." , The Adam Device offers a quick, effective ...
(Date:8/31/2015)... (PRWEB) , ... August 31, ... ... Lifestyle Medicine (ACLM), the nation’s medical professional association for physicians and allied ... conjunction with the Lifestyle Medicine Foundation, announced today the establishment of the ...
(Date:8/31/2015)... ... August 31, 2015 , ... MeYou Health ®, a social well-being ... walking app, Walkadoo , by including an in-app step tracker. , Walkadoo is ... person’s walking habits. Rather than broadly assign every Walkadoo member 10,000 steps a day ...
Breaking Medicine News(10 mins):Health News:Castle Dermatology Institute Now Welcomes Dr. Pedram Ghasri to the Practice 2Health News:On the Ball with FirstSpirit: German Soccer League (DFL Digital Sports) Opts for e-Spirit’s CMS 2Health News:InventHelp® Client's Invents Medical Device to Restore Respiratory Function (BGF-905) 2Health News:Nominations Sought for Awards Recognizing Exemplary Contribution to the Field of Lifestyle Medicine 2Health News:Nominations Sought for Awards Recognizing Exemplary Contribution to the Field of Lifestyle Medicine 3Health News:Walkadoo™ Walking Program Now Includes In-app Step Tracker 2
... A ... Radio Channel 160. This program is produced by KarenZupko & Associates, Inc., a Chicago-based ... media communications platform for medical professionals. , ... Chicago, IL (PRWEB) July 15, 2009 -- KarenZupko & Associates, ...
... ... Recovery of Personal Information a Cinch with Instant Access to Essential Documents and Files ... Los Angeles, ... complete document security and protection system that brings total peace of mind through highly ...
... ST. LOUIS and SAN FRANCISCO, July 15 /PRNewswire-FirstCall/ ... (R), a business segment within SAFC(R), a member of ... roadmap for Metalorganic Chemical Vapor Deposition (MOCVD) and Atomic Layer ... the development paths across current and future advanced memory and ...
... WASHINGTON, July 14 Speaker Nancy Pelosi, Majority Leader Steny Hoyer, Chairman Henry ... Democrats held a press conference in the Capitol this afternoon to discuss ... , , Below is a transcript of the ... Pelosi. Good afternoon. , , This ...
... State must comply - NOT DEFY - by close of ... 14 In a ruling issued late yesterday afternoon, Judge Wilken of the ... which halts the State,s plans to cut In-Home Supportive Services (IHSS) wages. , ... to the Governor that you can,t ignore the law, no matter who you ...
... , PHOENIX, July 14 Just weeks after the ... The World Egg Bank (TWEB) today announced a new loan program ... , Offered through Kansas-based Home National Bank, the program can ... or the total cost of an in vitro fertilization (IVF) procedure using fresh ...
Cached Medicine News:Health News:KarenZupko & Associates, Inc. and ReachMD XM 160 Announce New Radio Programming Series, "Practice Success" hosted by Karen Zupko 2Health News:KarenZupko & Associates, Inc. and ReachMD XM 160 Announce New Radio Programming Series, "Practice Success" hosted by Karen Zupko 3Health News:"The Safe" Way To Protect Against The Anguish Of Disaster Recovery 2Health News:"The Safe" Way To Protect Against The Anguish Of Disaster Recovery 3Health News:New SAFC Hitech(R) Product Roadmap Plots Route for Future Generation Semiconductor Materials 2Health News:New SAFC Hitech(R) Product Roadmap Plots Route for Future Generation Semiconductor Materials 3Health News:New SAFC Hitech(R) Product Roadmap Plots Route for Future Generation Semiconductor Materials 4Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 2Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 3Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 4Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 5Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 6Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 7Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 8Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 9Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 10Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 11Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 12Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 13Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 14Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 15Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 16Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 17Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 18Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 19Health News:Full Transcript of House Democrats' Press Conference on Introduction of Health Care Legislation 20Health News:Federal Judge Orders Schwarzenegger Administration to Comply with Order That Blocks State Reduction for IHSS Worker Wages 2Health News:New Fertility Financing for Donated Eggs Fills Void Left by Capital One 2
Stainless steel construction to withstand sterilization modalities (EtO, Steris, and Sterrad)...
Stainless steel construction to withstand sterilization modalities (EtO, Steris, and Sterrad) Wide angle of view...
Inquire...
Inquire...
Medicine Products: